Foveal structure during the induction phase of anti-vascular endothelial growth factor therapy for occult choroidal neovascularization in age-related macular degeneration

References

• WongTYChakravarthyUKleinRThe natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysisOphthalmology2008115911612617675159
   PubMed Web of Science ®Google Scholar
• FerraraNThe role of vascular endothelial growth factor in pathological angiogenesisBreast Cancer Res Treat19953621271378534862
   PubMed Web of Science ®Google Scholar
• BrownDMKaiserPKMichelsMANCHOR Study GroupRanibizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med2006355141432144417021319
   PubMed Web of Science ®Google Scholar
• RosenfeldPJBrownDMHeierJSMARINA Study GroupRanibizumab for neovascular age-related macular degenerationN Engl J Med2006355141419143117021318
   PubMed Web of Science ®Google Scholar
• HeierJSBrownDMChongVVIEW 1 and VIEW 2 Study GroupsIntravitreal aflibercept (VEGF trap-eye) in wet age-related macular degenerationOphthalmology2012119122537254823084240
   PubMed Web of Science ®Google Scholar
• HolashJDavisSPapadopoulosNVEGF-trap: a VEGF blocker with potent antitumor effectsProc Natl Acad Sci U S A20029917113931139812177445
   PubMed Web of Science ®Google Scholar
• EconomidesANCarpenterLRRudgeJSCytokine traps: multi-component, high-affinity blockers of cytokine actionNat Med200391475212483208
   PubMed Web of Science ®Google Scholar
• MargolisRSpaideRFA pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyesAm J Ophthalmol2009147581181519232559
   PubMed Web of Science ®Google Scholar
• OgasawaraMMarukoISuganoYOjimaASekiryuTIidaTRetinal and choroidal thickness changes following intravitreal ranibizumab injection for exudative age-related macular degenerationNihon Ganka Gakkai Zasshi2012116764364922844783
   PubMedGoogle Scholar
• YamazakiTKoizumiHYamagishiTKinoshitaSSubfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month resultsOphthalmology201211981621162722551738
   PubMed Web of Science ®Google Scholar
• KoizumiHKanoMYamamotoAAflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre studyBr J Ophthalmol20159991284128825777816
   PubMed Web of Science ®Google Scholar
• MazarakiKFassnacht-RiederleHBlumRBeckerMMichelsSChange in choroidal thickness after intravitreal aflibercept in pretreated and treatment-naïve eyes for neavascular age-related macular degenerationBr J Ophthalmol Epub2015
   Web of Science ®Google Scholar
• YingGSHuangJMaquireMGComparison of Age-related Macular Degeneration Treatments Trials Research GroupBaseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degenerationOphthalmology2013120112212923047002
   PubMed Web of Science ®Google Scholar
• HayashiHYamashiroKTsujikawaAOtaMOtaniAYoshimuraNAssociation between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degenerationAm J Ophthalmol200914818389.e119327745
   PubMed Web of Science ®Google Scholar
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials – TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study GroupArch Ophthalmol1999117101329134510532441
   PubMed Web of Science ®Google Scholar
• SpaideRFYannuzziLASlakterJSSorensonJOrlachDAIndocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathyRetina19951521001107542796
   PubMed Web of Science ®Google Scholar
• LalwaniGARosenfeldPJFungAEA variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO studyAm J Ophthalmol200914814358.e119376495
   PubMed Web of Science ®Google Scholar
• GharbiyaMIannettiLVisual and anatomical outcomes of intravitreal aflibercept for treatment-resistant neovascular age-related macular degenerationBiomed Res Int2014201427375424895562
   PubMed Web of Science ®Google Scholar
• JulienSBiesemeierATaubitzTSchraermeyerUDifferent effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyesBr J Ophthalmol201498681382524457369
   PubMed Web of Science ®Google Scholar
• WykoffCCBrownDMMaldonadoMECroftDEAflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial)Br J Ophthalmol201498795195524518078
   PubMed Web of Science ®Google Scholar
• KeanePALiakopoulosSChangKTRelationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degenerationOphthalmology2008115122206221418930551
   PubMed Web of Science ®Google Scholar
• MarukoIIidaTSuganoYOjimaAOgasawaraMSpaideRFSubfoveal choroidal thickness after treatment of central serous chorioretinopathyOphthalmology201011791792179920472289
   PubMed Web of Science ®Google Scholar
• SchnichelsSHagemannUJanuschowskiKComparative toxicity and proliferation testing of aflibercept, bevacizumab and ranibizumab on different ocular cellsBr J Ophthalmol201397791792323686000
   PubMed Web of Science ®Google Scholar
• SchraermeyerUJulienSFormation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eyeGraefes Arch Clin Exp Ophthalmol20122501303131322614910
   PubMed Web of Science ®Google Scholar
• StewartMWRosenfeldPJPredicted biological activity of intravitreal VEGF trapBr J Ophthalmol200892566766818356264
   PubMed Web of Science ®Google Scholar
• WangXSawadaTSawadaOSaishinYLiuPOhjiMSerum and plasma vascular endothelial growth factor concentrations before and after intravitreal injection of aflibercept or ranibizumab for age-related macular degenerationAm J Ophthalmol2014158473874424973606
   PubMed Web of Science ®Google Scholar
• MurinelloSMullinsRFLoteryAJPerryVHTeelingJLFcgamma receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degenerationInvest Ophthalmol Vis Sci201455124725824334446
   PubMed Web of Science ®Google Scholar
• KerntMNeubauerASLieglRGSorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGFBr J Ophthalmol201094111533153920962354
   PubMed Web of Science ®Google Scholar